Biodexa Pharmaceuticals Plc
BDRX
$7.57
$0.060.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.45% | -18.32% | -72.53% | -69.30% | -3.82% |
| Total Receivables | 117.61% | 105.34% | -0.18% | 11.55% | 20.54% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | 1,679.06% | 1,888.18% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 29.56% | 22.26% | 23.17% | 37.64% | 3.01% |
|
|
|||||
| Total Current Assets | 29.56% | 22.26% | 23.17% | 37.64% | 3.01% |
| Net Property, Plant & Equipment | -53.50% | -56.13% | -44.23% | -37.67% | -37.44% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.86% | -3.88% | 88.69% | 110.86% | 118,539.06% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 15.05% | 8.57% | 37.80% | 53.99% | 74.47% |
|
|
|||||
| Total Accounts Payable | -9.24% | -14.36% | 121.28% | 147.29% | -4.29% |
| Total Accrued Expenses | -- | -- | 46.00% | 63.15% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 4.09% | 16.34% | 5.52% |
| Total Finance Division Other Current Liabilities | -62.21% | -64.34% | -43.17% | -36.50% | 342.02% |
| Total Other Current Liabilities | -62.21% | -64.34% | -43.17% | -36.50% | 342.02% |
| Total Current Liabilities | -22.80% | -27.15% | -11.16% | -0.72% | 51.64% |
|
|
|||||
| Total Current Liabilities | -22.80% | -27.15% | -11.16% | -0.72% | 51.64% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -60.70% | -56.06% | -45.56% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -36.50% | -40.08% | -- | -- | -- |
| Total Liabilities | -29.92% | -33.87% | 8.24% | 20.96% | 95.72% |
|
|
|||||
| Common Stock & APIC | 11.75% | 5.46% | 4.48% | 16.75% | 11.08% |
| Retained Earnings | -12.99% | -6.62% | -2.13% | -14.12% | -5.82% |
| Treasury Stock & Other | 19.00% | 12.30% | 4.30% | 16.55% | 3.47% |
| Total Common Equity | 42.06% | 34.05% | 74.85% | 95.39% | 63.78% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 42.06% | 34.05% | 74.85% | 95.39% | 63.78% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 42.06% | 34.05% | 74.85% | 95.39% | 63.78% |
|
|
|||||